These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19258667)

  • 1. Vasopressin in vascular regulation and water homeostasis in the brain.
    Kozniewska E; Romaniuk K
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 8():109-16. PubMed ID: 19258667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin receptors in voiding dysfunction.
    Pisipati S; Hashim H
    Handb Exp Pharmacol; 2011; (202):453-83. PubMed ID: 21290239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational vasopressin receptor modulators in the pipeline.
    Favory R; Salgado DR; Vincent JL
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1119-31. PubMed ID: 19589090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body water balance and body temperature in vasopressin V1b receptor knockout mice.
    Daikoku R; Kunitake T; Kato K; Tanoue A; Tsujimoto G; Kannan H
    Auton Neurosci; 2007 Oct; 136(1-2):58-62. PubMed ID: 17512263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
    Streefkerk JO; van Zwieten PA
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):141-8. PubMed ID: 16553642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Humoral factors of regulation of water-salt metabolism in experimental traumatic brain edema].
    Gromov LA; Sereda PI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(12):14-6. PubMed ID: 1965360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptides in neurogenic disorders of the cardiovascular control.
    Szczepańska-Sadowska E
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 11():31-53. PubMed ID: 17244937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Prog Brain Res; 2008; 170():519-25. PubMed ID: 18655905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of vasopressin receptors in cerebral endothelial cells].
    Hess J; Meyer HW; Poeggel G; Kretzschmar R
    Acta Histochem Suppl; 1986; 33():79-83. PubMed ID: 3016797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of vasopressin antagonists.
    Sawyer WH; Manning M
    Fed Proc; 1984 Jan; 43(1):87-90. PubMed ID: 6317468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sea within us: disorders of body water homeostasis.
    Schrier RW
    Curr Opin Investig Drugs; 2007 Apr; 8(4):304-11. PubMed ID: 17458180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin and vasopressin receptor antagonists in heart failure.
    Oghlakian G; Klapholz M
    Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role of vasopressin in the brain: modulation of activity-dependent water flux in the neocortex.
    Niermann H; Amiry-Moghaddam M; Holthoff K; Witte OW; Ottersen OP
    J Neurosci; 2001 May; 21(9):3045-51. PubMed ID: 11312289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia in the neurosurgical patient: epidemiology, pathophysiology, diagnosis, and management.
    Fraser JF; Stieg PE
    Neurosurgery; 2006 Aug; 59(2):222-9; discussion 222-9. PubMed ID: 16883162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease.
    Petersen MB
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):96-103. PubMed ID: 16918709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water in health and disease: new aspects of disturbances in water metabolism.
    Peters HP; Robben JH; Deen PM; Wetzels JF
    Neth J Med; 2007 Oct; 65(9):325-32. PubMed ID: 17954951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance.
    Nakamura K; Aoyagi T; Hiroyama M; Kusakawa S; Mizutani R; Sanbe A; Yamauchi J; Kamohara M; Momose K; Tanoue A
    Eur J Pharmacol; 2009 Jun; 613(1-3):182-8. PubMed ID: 19375419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiology of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders.
    Schrier RW; Goldberg JP
    Yale J Biol Med; 1980; 53(6):525-41. PubMed ID: 7245804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.